---
title: "Citi Sticks to Its Buy Rating for Glaukos (GKOS)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292048170.md"
description: "Citi analyst Joanne Wuensch reiterated a Buy rating on Glaukos (GKOS) with a $175 price target. The stock closed at $148.70. Analyst consensus remains a Strong Buy with an average target of $160.60, implying 8% upside. Additionally, H.C. Wainwright initiated coverage with a Buy rating and a $168 target."
datetime: "2026-07-08T09:46:31.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292048170.md)
  - [en](https://longbridge.com/en/news/292048170.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292048170.md)
---

# Citi Sticks to Its Buy Rating for Glaukos (GKOS)

Citi analyst Joanne Wuensch reiterated a Buy rating on Glaukos on July 6 and set a price target of $175.00. The company’s shares closed yesterday at $148.70.

### 4th of July Sale - 70% Off

-   Unlock powerful investing tools and data-driven insights with TipRanks Premium for more confident investment decisions.
-   Discover top stock picks and new investment opportunities through TipRanks' Smart Investor Newsletter.

Wuensch covers the Healthcare sector, focusing on stocks such as Integra Lifesciences, Abbott Laboratories, and Edwards Lifesciences. According to TipRanks, Wuensch has an average return of 1.3% and a 52.74% success rate on recommended stocks.

Currently, the analyst consensus on Glaukos is a Strong Buy with an average price target of $160.60, representing an 8.00% upside. In a report released on July 6, H.C. Wainwright also initiated coverage with a Buy rating on the stock with a $168.00 price target.

### Related Stocks

- [GKOS.US](https://longbridge.com/en/quote/GKOS.US.md)
- [C.US](https://longbridge.com/en/quote/C.US.md)
- [IART.US](https://longbridge.com/en/quote/IART.US.md)
- [ABT.US](https://longbridge.com/en/quote/ABT.US.md)
- [EW.US](https://longbridge.com/en/quote/EW.US.md)
- [C-R.US](https://longbridge.com/en/quote/C-R.US.md)

## Related News & Research

- [Glaukos CFO Alex R. Thurman disposes of USD 1.6 million in common shares](https://longbridge.com/en/news/293383036.md)
- [Bank of New York Mellon Corp Sells 12,667 Shares of Glaukos Corporation $GKOS](https://longbridge.com/en/news/293838194.md)
- [BridgeBio: Buy Rating Reaffirmed on Strong Encaleret Data and Multi‑Asset Launch Outlook](https://longbridge.com/en/news/293508763.md)
- [Glaukos CFO Alex R. Thurman sells 10,000 shares for $1.55 million](https://longbridge.com/en/news/292542226.md)
- [Glaukos Chief Development Officer Tomas Navratil disposes of 716 shares for $99,571.96](https://longbridge.com/en/news/292128205.md)